[ Price : $8.95]
FDA approves a Bristol Myers Squibb NDA for plaque psoriasis drug Sotyktu (deucravacitinib), a first-in-class, oral, selective, al...[ Price : $8.95]
BioMarin Pharmaceutical tells FDA a patient participating in the companys hemophilia A Phase 3 gene therapy trial of valoctocogene...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Statement of Identity and Strength Content and Format of L...[ Price : $8.95]
Teva urges the U.S. Supreme Court to dismiss a GlaxoSmithKline argument that the high court should not hear Tevas appeal of a skin...[ Price : $8.95]
FDA clears a Boston Imaging 510(k) for its V7, an ultrasound system said to enhance image clarity.[ Price : $8.95]
FDA approves Spectrum Pharmaceuticals Rolvedon (eflapegrastim-xnst) injection for decreasing febrile neutropenia-associated infect...[ Price : $8.95]
FDA selects non-profit PATHs chief scientific officer David Kaslow as CBER Office of Vaccines Research and Review director.[ Price : $8.95]
Federal Register notice: FDA revokes two emergency use authorizations one issued to Becton Dickinson and the other to Talis Biome...